Depixus Email Format
Biotechnology ResearchÎle-de-france, France11-50 Employees
Depixus SAS is a life sciences technology company based in Paris, France, that develops and commercializes a platform centered on analyzing interactions between biomolecules in real time. The technology enables researchers to study individual molecular interactions at scale, supporting efforts to understand disease mechanisms and accelerate the development of therapies. The company operates within the biotechnology research sector and targets researchers and organizations engaged in drug discovery and translational science, offering a means to gain deeper insights into molecular behavior that can inform therapeutic strategies. Recent actions include the launch of MAGNA One, described as a laboratory instrument capable of analyzing biomolecular interactions at scale, reflecting the company's focus on expanding access to its interactomics technology. Depixus has established collaborations with industry partners and has appointed leadership to advance commercialization of its MAGNA technology, positioning itself as a specialized supplier within the interactomics space in the Île-de-France region.